FAKTOR OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 03:17:16 07/06/2024 pm IST | ||
| 2.44 EUR | -2.40% |
|
| Current month | -3.47% | ||
| 1 month | -18.30% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 07/24/07 | 2.44 | -2.40% |
| 06/24/06 | 2.5 | +0.81% |
| 05/24/05 | 2.48 | +1.22% |
| 04/24/04 | 2.45 | -2.39% |
| 03/24/03 | 2.51 | -3.09% |
Real-time BOERSE MUENCHEN
Last update June 07, 2024 at 03:17 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD2VEH |
| ISIN | DE000HD2VEH6 |
| Date issued | 21/02/2024 |
| Strike | 366.8 $ |
| Maturity | Unlimited |
| Parity | 23.57 : 1 |
| Emission price | 10.39 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.56 € |
|---|---|
| Lowest since issue | 2.13 € |
| Spread | 0.01 € |
| Spread % | 0.41% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.7
USD
Average target price
316.3
USD
Spread / Average Target
+3.46%
- Stock Market
- Certificates
- Certificat
